Treatment guidelinesPurpose of review Rheumatoid arthritis (RA) leads to significant joint damage and systemic complications. Available treatment options for RA has made it possible to achieve a good control over disease activity and improve patient outcomes. In this review, we discuss management ...
A multidisciplinary guideline development group was established to formulate this evidence-based diagnosis and treatment guidelines for rheumatoid arthritis (RA) in China. The grading of recommendations, assessment, development, and evaluation (GRADE) system was used to rate the quality of the evidence ...
Rheumatoid arthritis (RA) is characterised by severe joint and bone damage due to heightened autoimmune response at the articular sites. Worldwide annual i
REFERENCES Citations Guidelines Credits PATIENT RESOURCES Patient Instructions Highlights & Basics Rheumatoid arthritis (RA) is a chronic, erosive arthritis that requires early and aggressive treatment. Diagnosed clinically. Laboratory and radiographic testing provide prognostic information more often than diagn...
According to the ACR treatment guidelines for early RA, patients who have not taken disease-modifying antirheumatic drug (DMARD) therapy should start DMARD therapy regardless of the disease activity level. In patients with low disease activity and early disease, monotherapy with methotrexate is the pr...
Although the majority of patients experience improvement with treatment, some data suggest that less than half of patients experience sustained remissions (3). At least 10% of patients are eventually severely disabled despite full treatment (4). White people and women have a poorer ...
Biological agents used for the treatment of rheumatoid arthritis (RA) are associated with serious adverse events. Guidelines provide standards for the prescribing and monitoring of these drugs. In São Paulo, health litigation for access to medicines has fueled the demand for biological therapy. The...
While treatment guidelines are roughly followed, the delay in diagnosis and changes of healthcare are particularly worrisome and need to be addressed. Disclosure of Interest None declareddoi:10.1136/annrheumdis-2017-eular.5521LB FernandesFA Palacios...
Gordon KB, Ruderman EM. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach. J Am Acad Dermatol 2006;54(Suppl 2):S85–S91. ArticlePubMedGoogle Scholar Gladman DD, Helliwell P, Mease PJ, Nash P, Ritchlin C, Taylor W. Assessment of patients with psoriatic arthri...
Rituximab for the treatment of rheumatoid arthritis Rituximab has been approved by the United States Food and Drug Administration in combination with methotrexate for the treatment of rheumatoid arthritis in... AA Schuna - 《Cochrane Database Syst Rev》...